Virus Safety for Biotherapeutics: Testing and Clearance Strategies Following the ICH Q5A Revision
Planova S20N evaluation on PCC and IgG products
Addressing Continuous Bioprocessing Challenges From Virus Removal Perspective
New Generation Planova™ S20N Demonstrates Robust Performance for Multi-Specific Antibodies
Nanofiltration Strategies in Plasma Protein Process Development
BioEX Features and Applications
Important Considerations in Successful Viral Clearance Studies
Minimizing Resources in Developing Virus Filtration Process with Planova™ BioEX
Manufacturing Considerations for Virus Filtration Processes Using Planova™ BioEX